Drug Costs

House Energy and Commerce Committee Reconciliation Legislation Includes Sound Medicaid Drug Rebate Provision

Last night, the House Energy and Commerce Committee unveiled its recommendations for the House COVID-19 relief reconciliation bill, with a markup scheduled for February 11, 2021.  One sound Medicaid provision would, as of January 1, 2023, eliminate the current cap on total drug rebates that manufacturers must pay state Medicaid programs, which would produce significant […]

State-imported drugs would not affect 340B drug prices

Modern Healthcare By: Rachel Cohrs Drugs imported by states under the Trump administration’s importation plan will not be subject to Medicaid rebates, which means they would not set new 340B prices according to CMS guidance released Friday… The savings from drug importation would hinge on how low states could get drug prices and how widely […]

California Rx: State May Dive Into Generic Drug Market

Kaiser Health News By: Angela Hart and Samantha Young  California is poised to become the first state to develop its own line of generic drugs, targeting soaring drug prices and stepping into a fiercely competitive drug market dominated by deep-pocketed pharmaceutical companies… “Other legislative efforts in Congress and in other states have focused on government […]

CCF Comments to Trump Administration Medicaid Drug Rebate Rule

CCF has submitted public comments to the Centers for Medicare and Medicaid Services (CMS) on the proposed Medicaid drug rebate rule which, among other things, would change how drug manufacturers report “best price” under the effective Medicaid Drug Rebate Program. As I have explained, the proposed rule’s best price reporting changes are intended to facilitate […]